focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,771.00
Ask: 1,771.50
Change: -8.50 (-0.48%)
Spread: 0.50 (0.028%)
Open: 1,773.50
High: 1,779.00
Low: 1,764.50
Prev. Close: 1,783.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

Tue, 14th Nov 2023 17:04

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook.

A hold by the US central bank next month is now completely priced in. According to the CME FedWatch Tool, there was a 15% chance of a hike a day ago, as investors digested hawkish comments from Fed Chair Jerome Powell from last week.

The FTSE 100 index rose by 14.64 points, 0.2%, at 7,440.47. It represents a solid gain, though massively underperforming peers.

The FTSE 250 shot up 622.48 points, 3.5%, at 18,536.13, and the AIM All-Share rose 8.85 points, 1.3%, at 709.72.

The Cboe UK 100 rose 0.3% at 743.54, the Cboe UK 250 jumped 3.8% at 16,064.08, and the Cboe Small Companies surged 1.8% at 13,192.44.

In European equities on Tuesday, the CAC 40 in Paris surged 1.4%, while the DAX 40 in Frankfurt shot up 1.8%.

According to the Bureau of Labor Statistics, the consumer price index rose by 3.2% in October from a year before, slowing from a 3.7% increase in September. The inflation rate had been expected to cool only to 3.3%, according to FXStreet-cited market consensus.

The rate of inflation is now closer to the Fed's 2% target.

The core annual inflation rate eased to 4.0% in October from 4.1% in September, a pace it had been expected to maintain last month.

The Fed earlier in November left the federal funds rate range unmoved at 5.25% to 5.50%, a 22-year-high, and where it has been since July.

But hiking expectations picked up slightly after Chair Jerome Powell struck a hawkish tone last week.

Powell said Thursday that the Fed was prepared to hike again if needed.

The Fed chair's words gave the dollar some support towards the back end of last week, but the greenback was on the back foot on Tuesday, even prior to the inflation data.

Sterling was quoted at USD1.2475 late Tuesday afternoon, higher than USD1.2264 at the London equities close on Monday. The pound was trading around a two-month-high.

The euro traded at USD1.0855 on Tuesday afternoon, up from USD1.0696 at the London equities close on Monday. Against the yen, the dollar was quoted at JPY150.85, down versus JPY151.59.

Gold was quoted at USD1,964.57 an ounce late Tuesday, up from USD1,945.38 on Monday. The precious metal has an inverse relationship with the dollar.

In New York, the Dow Jones Industrial Average was up 1.7%, the S&P 500 surged 2.1% and the Nasdaq Composite jumped 2.3%, with tech shares benefitting from the cooler US inflation reading.

Interest rate sensitive stocks in London also shone. Warehouse investor Segro and housebuilder Taylor Wimpey added 6.4% and 8.1% as the property excelled in the wake of the US data, as rate worries eased.

It was not only in foreign currency and equity markets where moves were dramatic post-US data. The yield on the US 10-year Treasury eased markedly to as low as 4.43% following the data, from a high of 4.70% on Monday.

The stronger sterling meant the FTSE 100 was unable to rise as strongly as European peers. London's blue-chip index is stacked with international earners.

Index heavyweights such as GSK, Shell and Unilever fell 1.7%, 1.4% and 0.9%.

A hefty 5.5% fall for Vodafone also kept a lid on the FTSE 100. The Newbury, Berkshire-based telecommunications provider said pretax profit in the six months to September 30 dived to EUR550 million from EUR1.69 billion a year prior. Revenue fell 4.3% to EUR21.94 billion from EUR22.93 billion.

It swung to a net loss of EUR155 million, from profit of EUR1.20 billion.

At the other end of the FTSE 100, DCC surged 12%. It said revenue and profit both fell in the latest half year but declared an increased dividend.

The Dublin-based sales, marketing and support services firm said pretax profit for the six months that ended on September 30 was GBP129.7 million, down from GBP312.3 million the previous year.

Revenue fell 11% to GBP9.62 billion from GBP10.84 billion. This was mainly due to lower average commodity prices, which caused DCC Energy revenue to decrease 9.7% to GBP2.3 billion.

DCC nonetheless declared an interim dividend of 63.04 pence per share, up 5.0% from 60.04 pence the year before.

Elementis rose 5.2%. It set out a lofty margin target and said it plans "above market revenue growth by 2026".

The speciality chemicals firm, hosting a capital markets day in the wake of receiving calls from some shareholders for an immediate sale of the company, also said it is eyeing cost cuts.

London-based Elementis is looking for an adjusted operating profit margin above 19% as part of its 2026 financial targets. It achieved an adjusted operating profit margin of 13.6% in 2022, rising from 12.4% in 2021.

"The 19% target operating margin will be achieved through our growth and efficiency programmes based on current market conditions, whilst a modest recovery in the demand environment could see the margin rise above this level," Elementis said.

It is also targeting delivering "USD90 million of above market revenue growth by 2026".

The capital markets day comes after Elementis has faced shareholder scrutiny recently.

In September, Franklin Mutual Advisors, an investment advisory firm parented by Franklin Templeton, published an open letter requesting that the Elementis board "initiate an immediate sale of the company".

The targets announced by Elementis on Tuesday were not enough to win over Franklin.

"The proposed targets are based on multiple assumptions several years into the future. The current management has been in charge for nearly eight years and consistently disappointed shareholders with value destruction and missed targets. We continue to believe that the company should start a formal sales process to maximize shareholder value," Franklin Mutual Series Senior Vice President-Portfolio Manager Steve Raineri said.

AIM-listed Horizonte Minerals tumbled 48%. It said it will scale back construction activities at its Araguaia nickel asset in Brazil to manage its resources and funds.

Horizonte said it will be advancing only critical workstreams, as it attempts to save cash as it tries to secure more funding.

The Araguaia project had total liquidity sources of USD169 million at November 10, which it explained "should provide sufficient working capital to around mid-December 2023 unless there are positive outcomes from conversations with suppliers, other cash preserving measures, or other financing solutions".

It added that financing discussions with shareholders and lenders continue.

Brent oil was trading at USD83.42 a barrel at the time of the European equities, rising from USD82.39 a day prior.

Wednesday's economic calendar has China retail sales data and a Japanese gross domestic product reading overnight. There is UK inflation data at 0700 GMT, eurozone industrial production at 1000 GMT and a US producer price index at 1330 GMT.

The local corporate calendar has half-year results from utility firm SSE and pub company Fuller, Smith & Turner.

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
20 Feb 2024 15:10

PRESS: AJ Bell founder to join Applied Nutrition ahead of IPO - Sky

(Alliance News) - Supplements maker Applied Nutrition, plotting a London stock market float, is to add AJ Bell PLC founder Andy Bell as its chair, Sky News reported on Tuesday.

Read more
20 Feb 2024 08:55

IN BRIEF: Diageo welcomes GSK's CFO as non-executive director

Diageo PLC - London-based brewer and distiller sells more than 200 drinks brands, including Guinness stout, Captain Morgan rum and Johnnie Walker whisky - Appoints GSK PLC's chief financial officer and executive director, Julie Brown, as a non-executive director. Says she will succeed Alan Stewart as chair of the audit committee after his retirement following the firm's annual general meeting in September. Chair Javier Ferran says: "Julie brings many years of experience in financial, commercial and strategic roles in international companies operating in highly regulated industries. She is strongly committed to enabling diversity in business and to creating sustainable, long-term value for stakeholders. I look forward to her contribution to Board discussions and to working with her in progressing Diageo's ambition to be one of the most trusted and respected consumer products companies in the world."

Read more
15 Feb 2024 14:44

UK dividends calendar - next 7 days

Friday 16 February 
JPMorgan Asia Growth & Income PLCdividend payment date
JPMorgan Japan Small Cap Growth & Income PLCdividend payment date
Murray International Trust PLCdividend payment date
Premier Miton Group PLCdividend payment date
Schroder Oriental Income Funddividend payment date
Solid State PLCdividend payment date
Monday 19 February 
no events scheduled 
Tuesday 20 February 
Invesco Bond Income Plus Ltd 
Wednesday 21 February 
no events scheduled 
Thursday 22 February 
abrdn Asia Focus PLCex-dividend payment date
Alumasc Group PLCex-dividend payment date
AstraZeneca PLCex-dividend payment date
BlackRock Throgmorton Trust PLCex-dividend payment date
Braemar PLCex-dividend payment date
easyJet PLCex-dividend payment date
Ecofin US Renewables Infrastructure Trust PLCex-dividend payment date
Endeavour Mining PLCex-dividend payment date
FRP Advisory Group PLCex-dividend payment date
Gateley Holdings PLCex-dividend payment date
GSK PLCex-dividend payment date
Hercules Site Services PLCex-dividend payment date
Jersey Electricity PLCex-dividend payment date
Land Securities Group PLCex-dividend payment date
Molten Ventures VCT PLCex-dividend payment date
Northern Bear PLCex-dividend payment date
Redrow PLCex-dividend payment date
Samuel Heath & Sons PLCex-dividend payment date
Titon Holdings PLCex-dividend payment date
Unilever PLCex-dividend payment date
Van Elle Holdings PLCex-dividend payment date
Virgin Money UK PLCex-dividend payment date
Witan Investment Trust PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
15 Feb 2024 11:02

Berenberg hikes target price on GSK

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker GSK from £16.50 to £18.20 on Thursday, stating the group was moving closer to offsetting losses associated with the expiry of its patent on HIV drug dolutegravir.

Read more
15 Feb 2024 09:45

LONDON BROKER RATINGS: Jefferies cuts Kingfisher but Citi raises

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
15 Feb 2024 08:49

GSK completes USD1.4 billion purchase of respiratory firm Aiolos Bio

(Alliance News) - GSK PLC on Thursday said it has completed the acquisition of Aiolos Bio Ltd, expanding its respiratory portfolio with a potential "best-in-class" asthma treatment.

Read more
13 Feb 2024 16:53

LONDON MARKET CLOSE: Stocks in red amid sticky US inflation data

(Alliance News) - Stock prices in London closed in the red on Tuesday, after a key US inflation reading came in hotter-than-expected.

Read more
13 Feb 2024 16:21

London close: Stocks fall as US inflation tops expectations

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

Read more
13 Feb 2024 16:21

London close: Stocks fall as US inflation tops expectations

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

Read more
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:45

Citi ups recommendation on GSK to 'buy'

(Sharecast News) - Citi has upgraded its rating on vaccines and drugs blue chip GSK to 'buy' while also boosting its earnings estimates.

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
13 Feb 2024 07:45

LONDON BRIEFING: "Record" Tui quarter; Ultimate Products eyes payouts

(Alliance News) - London's FTSE 100 is to open ever-so-slightly lower on Tuesday, with trade set to be nervy ahead of the afternoon's US inflation data.

Read more
12 Feb 2024 17:11

London close: Stocks finish higher after very quiet Monday

(Sharecast News) - London markets managed modest gains by the close of a subdued trading session on Monday, with no significant corporate or economic catalysts driving movements.

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.